Technical Analysis for NVTA - Invitae Corporation

Grade Last Price % Change Price Change
grade F 18.145 0.86% 0.16
NVTA closed down 3.02 percent on Friday, October 11, 2019, on 1.59 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical NVTA trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.86%
Outside Day Range Expansion 0.86%
180 Bearish Setup Bearish Swing Setup -2.18%
Outside Day Range Expansion -2.18%
Narrow Range Bar Range Contraction -3.99%
NR7 Range Contraction -3.99%
Inside Day Range Contraction -3.99%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -7.23%
MACD Bullish Signal Line Cross Bullish -7.23%
NR7 Range Contraction -7.23%

Older signals for NVTA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Medicine Cancer Biology Genetics Medical Genetics Medical Tests Neurological Disorders Molecular Diagnostics Software Tools Genetic Disorders Neurology Cardiovascular Disorders Genetic Disorder
Is NVTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.75
52 Week Low 9.04
Average Volume 2,213,015
200-Day Moving Average 20.6297
50-Day Moving Average 22.3514
20-Day Moving Average 19.7365
10-Day Moving Average 18.812
Average True Range 1.1212
ADX 28.12
+DI 12.4679
-DI 24.4714
Chandelier Exit (Long, 3 ATRs ) 18.8964
Chandelier Exit (Short, 3 ATRs ) 20.8436
Upper Bollinger Band 22.179
Lower Bollinger Band 17.294
Percent B (%b) 0.14
BandWidth 24.751096
MACD Line -1.0617
MACD Signal Line -1.0764
MACD Histogram 0.0148
Fundamentals Value
Market Cap 783.37 Million
Num Shares 43.5 Million
EPS -2.73
Price-to-Earnings (P/E) Ratio -6.59
Price-to-Sales 9.34
Price-to-Book 5.59
PEG Ratio -0.46
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.11
Resistance 3 (R3) 20.32 19.82 19.75
Resistance 2 (R2) 19.82 19.28 19.72 19.63
Resistance 1 (R1) 18.91 18.95 18.66 18.70 19.52
Pivot Point 18.41 18.41 18.29 18.31 18.41
Support 1 (S1) 17.50 17.87 17.25 17.29 16.46
Support 2 (S2) 17.00 17.54 16.90 16.35
Support 3 (S3) 16.09 17.00 16.23
Support 4 (S4) 15.88